Pearl Huang Inducted into the 2026 Class of the AIMBE College of Fellows

Dunad Therapeutics is pleased to share that our CEO and President, Pearl S. Huang, has been elected to the 2026 Class of the American Institute for Medical and Biological Engineering College of Fellows.

The AIMBE College of Fellows brings together leaders across academia, industry, and medicine whose work is shaping the future of biomedical engineering. Dr. Huang’s election reflects a career dedicated to advancing innovative approaches in biotechnology, as well as a strong commitment to education and mentorship within the field.

At Dunad, we see this recognition as a reflection not only of individual achievement, but of the collaborative effort across teams and partners working to translate scientific insight into meaningful therapeutic progress. We are proud to support work that bridges disciplines and pushes the boundaries of what is possible in medicine.

Read more → Full press release.